Zeolite-iron oxide nanocomposite from fly ash formed a ‘clubbell’ structure: integration of cardiac biocapture macromolecules in serum on microelectrodes

A new zeolite-iron oxide nanocomposite (ZEO-IO) was extracted from waste fly ash of a thermal power plant and utilized for capturing aptamers used to quantify the myocardial infarction (MI) biomarker N-terminal prohormone B-type natriuretic peptide (NT-ProBNP); this was used in a probe with an integ...

Full description

Saved in:
Bibliographic Details
Published inMikrochimica acta (1966) Vol. 188; no. 6; p. 187
Main Authors Liu, Zhiqiang, Gopinath, Subash C. B., Wang, Zhifang, Li, Yibo, Anbu, Periasamy, Zhang, Wenlong
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.06.2021
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new zeolite-iron oxide nanocomposite (ZEO-IO) was extracted from waste fly ash of a thermal power plant and utilized for capturing aptamers used to quantify the myocardial infarction (MI) biomarker N-terminal prohormone B-type natriuretic peptide (NT-ProBNP); this was used in a probe with an integrated microelectrode sensor. High-resolution microscopy revealed that ZEO-IO displayed a clubbell structure and a particle size range of 100–200 nm. Energy-dispersive X-ray spectroscopy and X-ray photoelectron spectroscopy confirmed the presence of Si, Al, Fe, and O in the synthesized ZEO-IO. The limit of detection for NT-ProBNP was 1–2 pg/mL (0.1–0.2 pM) when the aptamer was sandwiched with antibody and showed the doubled current response even at a low NT-ProBNP abundance. A dose-dependent interaction was identified for this sandwich with a linear plot in the concentration range 1 to 32 pg/mL (0.1–3.2 pM) with a determination coefficient R 2  = 0.9884; y  = 0.8425x–0.5771. Without  sandwich, the detection limit was 2–4 pg/mL (0.2–0.4 pM) and the determination coefficient was R 2  = 0.9854; y  = 1.0996x–1.4729. Stability and nonfouling assays in the presence of bovine serum albumin, cardiac troponin I, and myoglobin revealed that the aptamer-modified surface is stable and specific for NT-Pro-BNP. Moreover, NT-ProBNP-spiked human serum exhibited selective detection. This new nanocomposite-modified surface helps in detecting NT-Pro-BNP and diagnosing MI at stages of low expression. Graphical abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0026-3672
1436-5073
DOI:10.1007/s00604-021-04834-w